Highlights
NASDAQ: PDLI       Pdl Biopharma Inc
Last Price Today's Change   Day's Range   Trading Volume
2.47   -0.23 (8.52%)  2.39 - 2.78  30,270,721

Overview

 
Avg Volume (4 weeks):26,991,493
4 Weeks Range:2.39 - 2.84
4 Weeks Price Volatility (%):
17.78%
52 Weeks Range:2.09 - 3.86
52 Weeks Price Volatility (%):
21.47%
Average Price Target: 7.00
Price Target Upside/Downside: +4.53

Headlines



No recent Headlines for this stock.


Business Background

PDL BioPharma Inc discovers and develops humanized monoclonal antibodies and receives royalties from nine marketed products licensed under PDL patents. The ESP Pharma acquisition brought marketed products to PDL in 2005, but because of a lack of strategic fit, PDL sold its commercial assets in early 2008. After paying a special dividend to shareholders, PDL has spun off its drug-discovery and -development business and plans to continue distributing royalty-based income to shareholders.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3721  2575  348  3248 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ADMP 1.781+0.511 
 LK 1.38+1.38 
 CTRM 0.393-0.032 
 WPX 9.43+0.48 
 SNDL 0.629-0.032 
 NIO 61.11+2.77 
 AZRX 2.33+1.09 
 F 11.40-0.13 
 BNGO 9.54+1.27 
 OBLN 5.951+0.761